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HIV infection has several oral manifestations, including 
oral candidiasis and oral hairy leucoplakia. Occasionally 
unusual presentations requiring rigorous investigations 
are seen, and in these cases the diagnosis sometimes 
remains a dilemma owing to limited investigation 
facilities.1-3 We present the case of a patient who 
presented with a puzzling oral lesion.
CASE HISTORY
A 35-year-old HIV-positive man first presented to the 
Infectious Diseases Institute, Kampala, in 2006. He had 
World Health Organization (WHO) stage IV disease 
with a history of oesophageal candidiasis, a baseline 
weight of 58 kg and a CD4+ count of 56 cells/µl. He 
was initiated on highly active antiretroviral therapy 
(HAART) using a combination of stavudine, lamivudine 
and nevirapine (Triomune-30) together with co-
trimoxazole prophylaxis. 
Six months after initiating ART, a follow-up CD4+ 
count had risen to 226 cells/µl. Subsequently the count 
rose to 298 cells/µl. 
In September 2008, the patient presented with a 
4-month history of drenching night sweats and 
high-grade fevers, his temperature being recorded as 
39.3oC and 39.7oC on two occasions. There was no 
history of cough, weight loss or loss of appetite. The 
results of investigations at this time were as follows: 
full blood count – leucocytopenia, 1.1×103/l ; ESR – 
25 mm/h; blood slide for malaria parasites – none 
seen; urinalysis – normal; chest radiograph – normal; 
abdominal ultrasound scan – hepatosplenomegaly with 
a suggestion of a haemangioma in the liver; serum 
cryptococcal antigen – negative; blood cultures – no 
bacterial growth after 7 days of incubation; TPHA – 
non-reactive. 
On the basis of the unrelenting fever the patient was 
started on tuberculosis (TB) treatment consisting of 
rifampicin, isoniazid, ethambutol and pyrazinamide. 
During this time his antiretroviral therapy was switched 
to zidovudine, lamivudine and efavirenz.
Two weeks after the start of TB treatment, the patient 
developed drug-induced hepatotoxicity and the TB 
treatment was stopped. A week later difficulty in 
swallowing and marked weight loss were noted. He 
was treated with fluconazole and acyclovir for a month 
with no improvement, at which time he was admitted.
Two months after stopping TB medication the liver 
enzymes stabilised and he was restarted on anti-TB 
medication. 
In January 2009, the patient presented with a 
3-week history of high-grade fever, loss of appetite, 
cervical lymphadenopathy and a 2-week history of 
pus discharge from a palatal perforation, which was 
treated with ceftriaxone and fluconazole (Fig. 1). 
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We describe the case of a 35-year-old HIV-positive man seen at the Infectious Diseases Institute, Kampala, 
Uganda, with a 2-week history of palatal perforation.
Fig. 1. Perforation of hard palate.
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An ENT consultation gave a presumptive diagnosis 
of histoplasmosis and the patient was initiated on 
amphotericin B.
The results of investigations at this stage were 
as follows: oral fistula swab – 2+ yeast cells, 2+ 
Gram-positive cocci and 3+ Gram-negative rods; 
no inflammatory cells seen. A complete blood count 
showed macrocytosis and mean corpuscular volume 
of 103 fl; CD4+ count (13 January) – 71 cells/µl (this 
was less than half the peak CD4+ count, prompting 
measurement of viral load to exclude immunological 
failure); viral load (13 January) – not detected, with 
a lower limit of detection of 400 copies; lymph node 
aspirate – polymorphonuclear leucocytes 3+, Gram-
negative rods 2+, Gram-positive cocci 1+, no acid- 
and alcohol-fast bacilli seen, Escherichia coli isolated; 
lymph node biopsy – fibrosis and chronic granulomatous 
inflammation with central necrosis and epitheloid cells, 
small organisms with halo extracellular and within-
macrophage cytoplasm. Morphological features were 
consistent with toxoplasma lymphadenitis (Fig. 2).
The patient did not return to the Institute. The first 
follow-up phone call (within a week) revealed that he 
was deteriorating and was too weak to come to the 
clinic, and when we called the next week we were told 
that he had died. Unfortunately, the histopathology 
results were only obtained after his death.
DISCUSSION
This case is an example of the rare oral lesions seen in 
HIV-infected patients in our clinic. We comprehensively 
reviewed the literature on bone and joint disease in 
association with HIV infection but did not find a case 
of toxoplasma-related bone disease. Toxoplasma 
infection of the oral cavity is uncommon.4 A case of 
intra-oral lymphadenitis secondary to toxoplasmosis 
has however been reported.4 
In our case defective cell-mediated immunity as a 
result of immunosuppression may have facilitated the 
rapid dissemination of toxoplasma,5 resulting in bone 
invasion causing bone disintegration and destruction.5
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Fig. 2. Intracellular organisms with prominent outlines 
indicated by arrows. 
